La Jolla Pharmaceutical Company Asset Turnover Ratio (LJPC), as of second quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
La Jolla Pharmaceutical Company  (NASDAQ: LJPC)
 

La Jolla Pharmaceutical Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the second quarter 2022, La Jolla Pharmaceutical's asset turnover ratio sequentially decreased to 0.47 in the second quarter (Jun 30 2022), but remained above the company's average. For every Dollar on the Balance Sheet, La Jolla Pharmaceutical Company realized $0.47 in annual sales.

Within sector 18 more businesses have achieved higher asset turnover ratio. While asset turnover ranking remained unchanged in the Second Quarter 2022 compared to previous quarter at no. 2214.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LJPC Asset Turnover Ratio (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter
Y / Y Asset Change -0.64 % 7.58 % 40.12 % 24.25 % -6.88 %
Y / Y Revenue Change -34.35 % -69.46 % 11.5 % 46.76 % 176.64 %
Asset Turnover Ratio (TTM) 0.47 0.52 0.77 0.82 0.82
LJPC's Total Ranking # 2214 # 2214 # 2214 # 2253 # 2200
Seq. Asset Change 3.1 % -4.79 % 0.93 % 0.29 % 11.63 %
Seq. Revenue Change 1.13 % -14.62 % -8.29 % -17.09 % -52.96 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 19
Healthcare Sector # 281
Overall Market # 2214

Asset Turnover Ratio Statistics
High Average Low
0.82 0.37 0.04
(Sep 30 2021)   (Dec 31 2018)




LJPC Company Profile • Back to LJPC Efficiency Comparisons • Compare LJPC Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2022 Assets at quarter ending Jun 30 2022
Innovage Holding Corp   1.26 $ 698.640  Millions$ 553.665  Millions
Rockwell Medical inc   1.25 $ 63.929  Millions$ 50.956  Millions
Sunwin Stevia International Inc.  1.24 $ 36.703  Millions$ 29.694  Millions
Procyon Corporation  1.22 $ 4.842  Millions$ 3.973  Millions
Hanger inc.  1.22 $ 1,175.519  Millions$ 966.849  Millions
Psychemedics Corporation  1.21 $ 26.130  Millions$ 21.651  Millions
Zynex inc   1.20 $ 142.995  Millions$ 118.903  Millions
Dynatronics Corporation  1.18 $ 44.338  Millions$ 37.517  Millions
Hca Healthcare Inc   1.18 $ 60,105.000  Millions$ 51,024.000  Millions
Mettler toledo International Inc   1.17 $ 3,865.367  Millions$ 3,306.643  Millions
Amedisys Inc  1.15 $ 2,215.949  Millions$ 1,925.998  Millions
Reflect Scientific Inc  1.14 $ 2.854  Millions$ 2.507  Millions
Iridex Corp  1.14 $ 54.762  Millions$ 48.225  Millions
Infusystem Holdings Inc  1.10 $ 106.890  Millions$ 97.357  Millions
Cano Health Inc   1.08 $ 2,329.781  Millions$ 2,149.198  Millions
Viemed Healthcare Inc   1.08 $ 126.812  Millions$ 117.090  Millions
Organogenesis Holdings Inc   1.08 $ 461.829  Millions$ 426.578  Millions
Precision Optics Corporation Inc   1.08 $ 15.678  Millions$ 14.490  Millions
Advanced Container Technologies Inc   1.08 $ 4.383  Millions$ 4.051  Millions
Electromed Inc   1.07 $ 41.659  Millions$ 38.848  Millions
Cardiff Lexington Corporation  1.07 $ 12.966  Millions$ 12.105  Millions
Phibro Animal Health Corporation  1.07 $ 942.261  Millions$ 881.312  Millions
Fuse Medical Inc   1.07 $ 19.531  Millions$ 18.287  Millions
Yunhong Green Cti Ltd   1.06 $ 20.559  Millions$ 19.389  Millions
Interpace Biosciences Inc   1.05 $ 40.054  Millions$ 38.145  Millions
Inspire Medical Systems inc   1.04 $ 300.851  Millions$ 288.925  Millions
Xtant Medical Holdings Inc   1.03 $ 55.982  Millions$ 54.092  Millions
Enzo Biochem Inc  1.03 $ 107.071  Millions$ 104.181  Millions
Biocept Inc   1.02 $ 62.002  Millions$ 60.612  Millions
Shockwave Medical Inc   1.01 $ 363.715  Millions$ 358.586  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.